Daniel E. O’Flynn

Statistics

Publications

Citations

120

H-Index

Active since

2014

Affiliations

Syngenta (United Kingdom)(Current)

University of Bristol

Syngenta (China)

Daniel E. O’Flynn is an author at Syngenta (United Kingdom) specializing in microbial natural product biosynthesis, metabolism, and medicinal chemistry.

Publications per year

2014–2020

Publications

Asymmetrically Substituted Quadruplex-Binding Naphthalene Diimide Showing Potent Activity in Pancreatic Cancer Models

Ahmed A. Ahmed, Richard Angell, Sally Oxenford et al. · ACS Medicinal Chemistry Letters · 2020 · 57 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Novel nonadride, heptadride and maleic acid metabolites from the byssochlamic acid producer Byssochlamys fulva IMI 40021 – an insight into the biosynthesis of maleidrides

Agnieszka J. Szwalbe, Katherine Williams, Daniel E. O’Flynn et al. · Chemical Communications · 2015 · 34 citations · Full text

Life Sciences, Biochemistry, Biotechnology +10

Uncovering biosynthetic relationships between antifungal nonadrides and octadrides

Kate M. J. de Mattos-Shipley, Catherine E. Spencer, Claudio Greco et al. · Chemical Science · 2020 · 15 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Lead identification and structure–activity relationships of heteroarylpyrazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists

Afjal H. Miah, Royston C. B. Copley, Daniel E. O’Flynn et al. · Organic & Biomolecular Chemistry · 2014 · 14 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–4 of 4